Condition

Myeloid Leukemia, Chronic, Chronic Phase (3)

Leukemia, Chronic Myeloid (1)

Myeloid Leukemia, Chronic, Accelerated Phase (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Asan Medical Center (1)

Newcastle University (1)

Takeda (1)

Collaborator

Bristol-Myers Squibb (1)

Hammersmith Hospitals NHS Trust (1)

Institute of Cancer Research, United Kingdom (1)

Newcastle-upon-Tyne Hospitals NHS Trust (1)

Intervention

dasatinib (1)

diagnosed as cml (1)

imatinib (1)

ponatinib (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational [Patient Registry] (1)

Myeloid Leukemia, Chronic, Chronic Phase

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

Active, not recruiting

Has Results

Myeloid Leukemia, Chronic, Chronic Phase

Ponatinib

Atlanta, Georgia
+85 more

Jan 4, 2022

Leukemia, Chronic Myeloid, Myeloid Leukemia, Chronic, Accelerated Phase, Myeloid Leukemia, Chronic, Chronic Phase Trial in Seoul

Terminated

Leukemia, Chronic Myeloid
+2 more

Diagnosed as CML

Seoul, Korea, Republic of

Asan Medical Center

Jul 19, 2018

Myeloid Leukemia, Chronic, Chronic Phase Trial in Newcastle-upon-Tyne (Imatinib, Dasatinib)

Completed

Myeloid Leukemia, Chronic, Chronic Phase

Newcastle-upon-Tyne, United Kingdom

Freeman Hospital

Apr 20, 2018